Engineering pharmaceutical fine particles of budesonide for Dry Powder Inhalation (DPI)

Industrial and Engineering Chemistry Research

Volumn 47, Issue 23, 2008, Pages 9623-9627

  Hu, Ting Ting ^a   Zhao, Hong ^a   Jiang, Li Chuan ^a   Le, Yuan ^a   Chen, Jian Feng ^a   Yun, Jimmy ^b  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b NanoMaterials Technology Pte Ltd   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; AGGLOMERATION; CELLULOSE DERIVATIVES; DRUG PRODUCTS; METHANOL; POWDERS; TERNARY SYSTEMS; WATER PIPING SYSTEMS; WATERWORKS;

ANTISOLVENT PRECIPITATIONS; BUDESONIDE; CRYSTALLINE STRUCTURES; DISPERSIBILITY; DRY POWDER INHALATIONS; ELLIPSOIDAL PARTICLES; FINE PARTICLES; FLAKY PARTICLES; HYDROXYPROPYL CELLULOSES; IN VITRO; PULMONARY DELIVERIES; RECTANGULAR SHAPES; WATER SYSTEMS; X-RAY DIFFRACTIONS;

PRECIPITATION (CHEMICAL);

ACETONE; AGGLOMERATION; CELLULOSE DERIVATIVES; CHEMICALS; DRUGS; METHANOL; POWDER; PRECIPITATION; WATER SUPPLY;

EID: 57949110108     PISSN: 08885885     EISSN: None     Source Type: Journal    
DOI: 10.1021/ie0715052     Document Type: Article

References (28)

1. Kinnarinen, T.; Jarno, P.; Järvinen, K.; Järvinen, T. Pulmonary deposition of a budesonide/γ-cyclodextrin complex in vitro. J. Controlled ReI 2003, 90, 197.
2. Timsina, M. P.; Martin, G. P.; Marriott, C.; Ganderton, D.; Yianneskis, M. Drug delivery to the respiratory tract using dry powder inhalers. Int. J. Pharm. 1994, 101, 1.
3. Suarez, S.; Hickey, A. J. Drug properties affecting aerosol behavior. Resp. Care. 2000, 45, 652.
4. Telko, M. J.; Hickey, A. J. Dry powder inhaler formulation. Resp. Care. 2005, 50, 1209.
5. Hickey, A. J.; Martonen, T. B.; Yang, Y. D. Theoretical relationship of lung deposition to the fine particle fraction of inhalation aerosols. Pharm. Acta Helv. 1996, 71, 185.
6. Larhrib, H.; Martin, G. P.; Marriott, C.; Prime, D. The influence of carrier and drug morphology on drug delivery from dry powder formations. Int. J. Pharm. 2003, 257, 283.
7. Bosquillon, C.; Lombry, C.; Préat, V.; Vanbever, R. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J. Controlled Release 2001, 70, 329.
8. Chew, N. Y. K.; Chan, H. K. The role of particle properties in pharmaceutical powder inhalation formulations. J. Aerosol Med. 2002, 15, 325.
9. Rasenack, N.; Müller, B. W. Micro-size drug particles: common and novel micronization techniques. Pharm. Dev. Technol. 2004, 9, 1.
10. Martin, T. M.; Bandi, N.; Shulz, R.; Roberts, C. B.; Kompella, U. B. Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology. AAPS PharmSciTech. 2002, 3, 1.
11. Velaga, S. P.; Berger, R.; Carlfors, J. Supercritical fluids crystallization of budesonide and flunisolide. Pharm. Res. 2002, 19, 1564.
12. Bandi, N.; Wei, W.; Roberts, C. B.; Kotra, L. P.; Kompella, U. B. Preparation of budesonide- and indomethacin-hydroxypropyl-β-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process. Eur. J. Pharm. Sci. 2004, 23, 159.
13. Lobo, J. M.; Schiavone, H.; Palakodaty, S.; York, P.; Clark, A.; Tzannis, S. T. SCF-engineered powders for delivery of budesonide. J. Pharm. Sci. 2005, 94, 2276.
14. Porta, G. D.; Vittori, C. D.; Reverchon, E. Supercritical Assisted Atomization: a novel technology for microparticles preparation of an asthmacontrolling drug. AAPS PharmSciTech. 2005, 6, E421.
15. Steckel, H.; Pichert, L.; Müller, B. W. Influence of process parameters in the ASES process on particle properties of budesonide for pulmonary delivery. Eur. J. Pharm. Biopharm. 2004, 57, 507.
16. Steckel, H.; Thies, J.; Müller, B. W. Micronizing of steroids for pulmonary delivery by supercritical carbon dioxide. Int. J. Pharm. 1997, 152, 99.
17. Ruch, F.; Matijevic, E. Preparation of micrometer size budesonide particle by precipitation. J. Colloid Interface Sci. 2000, 229, 207.
18. Rasenack, N.; Steckel, H.; Müller, B. W. Micronization of antiinflammatory drugs for pulmonary delivery by a controlled crystallization process. J. Pharm. Sci. 2003, 92, 35.
19. Zhang, J. Y.; Shen, Z. G.; Zhong, J.; Hu, T. T.; Chen, J. F.; Ma, Z. Q. Preparation of Amorphous Cefuroxime Axetil Nanoparticles by Controlled Nanoprecipitation Method without Surfactants. Int. J. Pharm. 2006, 323, 153.
20. Chen, J. F.; Zhang, J. Y.; Shen, Z. G.; Zhong, J.; Yun, J. Mass Production and Characterization of Amorphous Cefuroxime Axetil Drug Nanoparticles with Novel Technology: High-gravity Antisolvent Precipitation. Ind. Eng. Chem. Res. 2006, 45, 8723.
21. Chiou, H.; Li, L.; Hu, T. T.; Chan, H. K.; Chen, J. F.; Yun, J. Production of a high-performance salbutamol sulfate for inhalation by highgravity antisolvent precipitation. Int. J. Pharm. 2007, 337, 93.
22. Li, X. S.; Wang, J. X.; Shen, Z. G.; Zhang, P. Y.; Chen, J. F.; Yun, J. Preparation of uniform prednisolone microcrystals by a controlled mcroprecipitaition method. Int. J. Pharm. 2007, 342, 26.
23. Zhao, H.; Wang, J. X.; Wang, Q. A.; Chen, J. F.; Yun, J. Controlled Liquid Antisolvent Precipitation of Hydrophobic Pharmaceutical Nanoparticles in MicroChannel Reactor. Ind. Eng. Chem. Res. 2007, 46, 8229.
24. Wang, Z.; Chen, J. F.; Le, Y.; Shen, Z. G.; Yun, J. Preparation of untrafine beclomethasone dipropionate drug powder by antisolvent precipitation. Ind. Eng. Chem. Res. 2007, 46, 4839.
25. Ikegami, K.; Kawashima, Y.; Takeuchi, H.; Yamamoto, H.; Isshiki, N.; Mosose, D.; Ouchi, K. Primary crystal growth during spherical agglomeration in liquid: designing an ideal dry powder inhalation system. Powder Technol. 2002, 126, 266.
26. Chew, N. Y. K.; Tang, P.; Chan, H. K.; Raper, J. A. How much partile surface corrugation is sufficient to improve aerosol performance of powders? Pharm. Res. 2005, 22, 148.
27. Chan, H.-K. Dry powder aerosol drug delivery-Opportunities for colloid and surface scientists. Colloids Surf. A: Physicochem. Eng. Aspects 2006, 284-285, 50.
28. Kawashima, Y.; Serigano, T.; Hino, T.; Yamamoto, H.; Takeuchi, H. Effect of surface morphology of carrier lactose on dry powder inhaltion property of pranlukast hydrate, Int. J. Pharm. 1998, 172, 179.